Virginia Volpe

7PUBLICATIONS
55CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2026
Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Oct 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Sep 02, 2022
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.

Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson

|Jun 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.

Virginia O Volpe, Najla Al Ali, Onyee Chan

|Jan 28, 2021
Treatment options for lower-risk myelodysplastic syndromes. Where are we now?

Virginia O Volpe, Rami S Komrokji

Pageof 2

Frequent Collaborators

4 joint publications

Jacqueline S Garcia

4 joint publications

Eric S Winer

4 joint publications

Evan C Chen

4 joint publications

Marlise R Luskin